Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

Prevention of Preterm Delivery with Compounded 17a-Hydroxyprogesterone Caproate

Author(s):  Reed-Kane Dana, Kirshbaum Karen

Issue:  May/Jun 2006 - Hormone Replacement Therapy
View All Articles in Issue

Page(s):  165-171

Prevention of Preterm Delivery with Compounded 17a-Hydroxyprogesterone Caproate Page 1
Prevention of Preterm Delivery with Compounded 17a-Hydroxyprogesterone Caproate Page 2
Prevention of Preterm Delivery with Compounded 17a-Hydroxyprogesterone Caproate Page 3
Prevention of Preterm Delivery with Compounded 17a-Hydroxyprogesterone Caproate Page 4
Prevention of Preterm Delivery with Compounded 17a-Hydroxyprogesterone Caproate Page 5
Prevention of Preterm Delivery with Compounded 17a-Hydroxyprogesterone Caproate Page 6
Prevention of Preterm Delivery with Compounded 17a-Hydroxyprogesterone Caproate Page 7

Download in electronic PDF format for $65

Abstract:  17a-hydroxyprogesterone caproate is a naturally occurring metabolite of progesterone that is produced in significant quantities during pregnancy. The demand for 17a hydroxyprogesterone caproate, the lack of a commercially available manufactured form approved by the US Food and Drug Administration, and publication of the results of a large trial to determine the effectiveness of the drug in the prevention of preterm delivery have spawned an increased interest in compounded formulations of the drug. The demand also has necessitated a review of the available literature and of past clinical studies, and a look at present and planned studies. Owing to the importance of this drug in pregnancy and the need for safety, accuracy in potency, and sterility in an intramuscular injection (the most common route of administration), compounding pharmacies must be in compliance with the United States Pharmacopeia Chapter <797> standards should they wish to compound this formulation.

Related Keywords: Dana Reed-Kane, PharmD, FIACP, FACA, FCP, NFPPhC, Karen Kirschbaum, PhD, women, pregnancy, preterm labor, 17a-hydroxyprogesterone caproate, risk factors, progesterone, preterm delivery

Related Categories: LEGAL, STERILE PREPARATIONS, UNITED STATES PHARMACOPEIA CONVENTIONS, DOSAGE FORMS/DRUG CARRIERS, ENDOCRINOLOGY/HORMONES/ MENOPAUSE/ANDROPAUSE

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Prevention of Preterm Delivery with Compounded 17a-Hydroxyprogesterone Caproate
Reed-Kane Dana
, Kirshbaum Karen
May/Jun 2006
Pg. 165-171

Case Report: Hydroxyprogesterone Caproate Injection for Prevention of Preterm Labor
Fields Shannon W
May/Jun 2006
Pg. 172

A Retrospective Observational Case Series Analysis of the Usage of Hydroxyprogesterone Caproate for the Prevention of Preterm Labor in Alabama Patients
Nolan Sara M
, Burgess Christopher A
Nov/Dec 2011
Pg. 446-448

Patient Satisfaction with Pharmacist Intervention and Consultation in Hormone Replacement Therapy: An Update
Hu Fei-Shu
, Reed-Kane Dana, Draugalis JoLaine R
May/Jun 2006
Pg. 187-192

Book Review: The Medical & Surgical Practice of NaProTECHNOLOGY
Reed-Kane Dana
Jan/Feb 2005
Pg. 5-6

Quality-Control Analytical Methods: Applications and Sterility of Autologous Eye Drops
Reed-Kane Dana
, Carlson Rachel A, Kupiec Thomas C, Vu Nicole
Nov/Dec 2009
Pg. 540-543

Book Review: Bacteria for Breakfast: Probiotics for Good Health
Reed-Kane Dana
Mar/Apr 2005
Pg. 93

Book Review: Miracle Cure: How to Solve America's Health Care Crisis and Why Canada Isn't the Answer
Reed-Kane Dana
Mar/Apr 2005
Pg. 93-94

Book Review: HRT: The Answers. A Concise Guide for Solving the Hormone Replacement Therapy Puzzle
Reed-Kane Dana
Nov/Dec 2004
Pg. 412

Book Reviews: Veterinary Drug Handbook: Client Information Edition
Reed-Kane Dana
May/Jun 2005
Pg. 173

Particle Measuring Systems - USP <797> Environmental Monitoring Solutions